WBC, lymphnodes, spleen and thymus pg

WBC, LYMPHNODES, SPLEEN AND THYMUS
  1. Role of eosinophils in health and disease (YSR UHS, Nov 2023)
  2. Maltoma (NTRUHS, June  2023)
  3. Minimal residual disease in leukemia  (NTRUHS, June  2023)
  4. Extra nodal lymphoma (NTRUHS, June  2023)
  5. Discuss the molecular genetics, classification and prognostic indicators in Hodgkins lymphoma (SVIMS, June 2023)
  6. Discuss the revised criteria and lab diagnosis of multiple myeloma (SVIMS, June 2023)
  7. Discuss the revised classification of acute leukemia (SVIMS, June 2023)
  8. Discuss the cytogenetics and molecular basis of classification of Acute myeloid leukemia (NTRUHS Dec 2022)
  9. Diagnostic approach for lymphnode plasma cell infiltrate  (NTRUHS Nov 2021)
  10. Discuss the role of cytogenetics in acute leukemias  (SVIMS April 2022)
  11. Describe the role of flow cytometry in acute leukemias (SVIMS , April 2022)
  12. Lineage associated markers in routine flow cytometry (NTRUHS, Nov 2021)
  13. Discuss hematological changes during pregnancy (SVIMS April 2021)
  14. Discuss myelodysplastic syndrome including recent updates (SVIMS April 2021)
  15. Classify mastocytosis. Discuss the diagnostic criteria and pathology of systemic mastocytosis (SVIMS April 2021)
  16. Sezary syndrome (NIMS,April 2021)
  17. Discuss briefly the principles of flow cytometry and its role in diagnosis of acute leukemia (NIMS, April 2021)
  18. Indolent myeloid disorders that lead to development of MDS (SVIMS, April 2021)
  19. risk stratification, prognostic factors in multiple myeloma (SVIMS, April 2021)
  20. Pathogenesis of myelofibrosis (SVIMS, April 2021)
  21. Discuss the laboratory diagnosis of chronic myeloproliferative disorders (NTRUHS, November 2020)
  22. Common cytogenetic abnormalities associated with AML (NTRUHS, November 2020)
  23. Discuss the differential diagnosis of follicular/nodular patterned nodal lymphomas (NTRUHS .2018)
  24. Discuss monoclonal gammopathy of uncertain significance (NTRUHS .2018)
  25. Discuss theDiscuss the features of castleman disease (RGUHS 2018)
  26. Discuss the role of cytokines and its receptors in differentiation of T cells (2018)
  27. Dendritic cells distribution and their diseases (2018)
  28. Discuss familial qualitative disorders of leukocytes (2018)
  29. Discuss immunological aspects of transplantation (2018)
  30. Cytogenetic abnormalities in CLL (Chronic Lymphocytic Leukemia) and their relevance
  31. Prognostic factors in acute leukemia
  32. Myelofibrosis and its  Pathogenesis
  33. Discuss Bone marrow transplantation in detail
  34. Define, classify and describe the laboratory diagnosis of acute leukemia
  35. Uses of colony stimulating factors
  36. Methods of detection of Minimal residual disease in acute leukemia.
  37. Minimal residual disease
  38. Myelodysplastic syndrome.- Definition, classification, pathology & lab diagnosis
  39. WHO classification of leukemias
  40. Refractory anemia
  41. Lab diagnosis of lymphomas using modern amenities.
  42. Erythroleukemia
  43. Leukocyte function tests.
  44. Preleukemic syndromes
  45. Infectious mononucleosis
  46. Blast crisis
  47. Hairy cell leukemia
  48. Leukemoid reactions.
  49. Classify plasma cell dyscrasias & their lab diagnosis.
  50. Molecular basis of APML.
  51. Prognostic factors in ALL
  52. Diagnostic criteria for myeloma
  53. Morphology of primary myelofibrosis
  54. Molecular cytogenetics of hematological malignancies.
  55. Role of bone marrow biopsy in the diagnosis of haematological disorders
  56. Chromosomal abnormalities in childhood acute leukemia
  57. Classifications of leukemias. CML.
  58. Bone marrow in health & disease
  59. Waldenstrom’s macroglobulinemia
  60. Lazy leukocytic syndrome
  61. Discuss Acquired Neutropenia
  62. Chronic myeloproliferative disorders
  63. Morphology of blast cells in Acute Leukaemia
  64. Discuss the causes of pancytopenia. Describe the lab methods in the investigation of a patient with  pancytopenia
  65. The WHO Classification of acute myeloid leukaemia (AML).
  66. Complications of Bone marrow Transplantations
  67. Leucocyte function disorders
  68. Discuss Histopathologic classification of Hodgkin’s disease. Add a note on unusual histopathologic variants and HD association with other Lymphoproliferative diseases.
  69. Discuss plasma cell dyscrasias in detail
  70. Immunophenotyping of Acute leukemias
  71. Prognostic factors in Multiple Myeloma
  72. Discuss the chromosomal aberrations in acute leukemias and their significance
  73. Splenomegaly
  74. Mantle cell lymphoma
  75. Polymorphonuclear leukocyte granules
  76. Classify Non Hodgkin lymphomas
  77. Extramedullary myeloid cell tumours
  78. Polycythemia vera
  79. Monoclonal gammapathy 
  80. Hypoplastic acute leukemia.
  81. Molecular basis of mixed lineage leukemia
  82. Pathogenesis and lab diagnosis of hypereosinophilic syndrome.
  83. Diagnostic criteria of multiple myeloma
  84. Prolymphocytic leukemia and its differential diagnosis.
  85. Hypersplenism
  86. Hyposplenism
  87. Splenic aspirate
  88. Kikuchi’s lymphadenitis
  89. Histological patterns of HIV- related lymphadenopathy
  90. Discuss recent advances in classification and pathogenesis of Burkitt’s lymphoma.
  91. Cystic lesions of spleen
  92. Hematolymphoid and tumor like conditions of spleen
  93. Childhood leukemias (RGUHS July 2020)
  94. Minimal residual disease (RGUHS July 2020)
  95. Classification of thymic neoplasms (RGUHS July 2020)
  96. Discuss the recent advances in Hodgkins disease (RGUHS 2018, July 2020)
  97. Kimuras disease (RGUHS 2018)
  98. Extranodal lymphoma (RGUHS 2018)
  99. Hairy cell leukemia (RGUHS 2018)
  100. Lazy leukocyte syndrome (RGUHS 2018)
  101. Adult T cell Leukemia (RGUHS 2018)
  102. WHO Classification of AML (RGUHS Nov 2018,  MAY 2017)
  103. Systemic mastocytosis (RGUHS 2018, JIPMER Mar 2016, OCT 2012)
  104. Pitfalls in the interpretation of lymphnode biopsies (RGUHS 2018)
  105. Castleman’s disease (RGUHS 2018)
  106. Classify Acute leukemias. Describe the morphology of cells in each type (RGUHS 2018)
  107. Molecular basis of acute promyclocytic leukemia (RGUHS MAY 2010)
  108. Discuss the recent advances in the classification and pathogenesis of Burkitt’s lymphoma (RGUHS MAY 2010)
  109. Anaplastic large cell lymphoma (RGUHS MAY 2010)
  110. Lab diagnosis of acute leukemia (RGUHS OCT 2010)
  111. Chronic myeloid leukemia (RGUHS SEP 2007)
  112. Lab diagnosis of lymphoma using modern amenities (RGUHS MAY 2007)
  113. Nodal lesions in HIV infection. (RGUHS Apr 2007)
  114. FAB classification of leukemias (RGUHS MAY 2007)
  115. Describe the peripheral blood picture and bone marrow findings in different phases of CML (RGUHS SEP 2007)
  116. Leucoeythroblastic reaction (RGUHS SEP 2007)
  117. Non neoplastic lesions of lymphnodes (RGUHS MAY 2007)
  118. Burkitts lymphoma (RGUHS MAY 2007)
  119. Mycosis fungoides (RGUHS MAY 2007)
  120. Classify lymphomas and discuss their pathology and the tools used in their diagnosis (RGUHS SEP 2007)
  121. Anaplastic large cell lymphoma (RGUHS NOV 2016,MAY 2007)
  122. Classify B cell non Hodgkins lymphoma according to the WHO 2008 classification scheme .Discuss the role of morphology, immunohistochemistry and molecular techniques in the diagnostic approach to a low grade B cell non Hodgkin’s lymphoma (JIPMER OCT 2012)
  123. Immunophenotype and genetic printing of Burkitt’s lymphoma (JIPMER OCT 2016)
  124. MYC driven lymphoma (JIPMER OCT 2016)
  125. Discuss the pathogenesis, morphology, cytogenesis and prognostic factors of myelodysplastic syndromes (JIPMER MAR 2016)
  126. Chronic lymphoproliferative disorder (JIPMER MAR 2016)
  127. Classify plasma cell dyscrasias. Discuss the genetic abnormalities and laboratory diagnosis of plasma cell myeloma. What are the factors associated with poor prognosis (JIPMER JULY 2016)
  128. Minimal residual disease in CML (JIPMER JULY 2016)
  129. Cytogenesis and immunophenotyping of acute myeloid leukemia (NBE DEC 2016)
  130. What is leukaemoid reaction? How would you differentiate it from chronic myeloid leukemia (NBE DEC 2016)
  131. Role of flow cytometry in chronic lymphoproliferative disorders (NBE DEC 2016)
  132. Differential diagnosis of Hairy cell leukemia (NBE DEC 2016)
  133. Mastocytosis (NBE DEC 2016)
  134. Discuss the role of molecular genetics and prognostic factors in chronic lymphocytic leukemia (JIPMER MAR 2011)
  135. Give a detailed account of WHO classification and laboratory diagnosis of acute myeloblastic leukemia (JIPMER MAR 2012)
  136. Hypereosinophilia-causes and approach to diagnosis (JIPMER OCT 2012)
  137. Classify myelodysplastic syndrome. Describe the blood and bone marrow findings. Write a note on cytogenetics in myelodysplastic syndrome (JIPMER Mar 2013)
  138. Discuss the laboratory diagnosis of multiple myeloma with special reference to prognostication of a case of myeloma (JIPMER Mar 2013)
  139. Laboratory diagnosis and prognostic features of chronic lymphocytic leukemia (JIPMER Mar 2014)
  140. Monoclonal gammopathy of undetermined significance (JIPMER Mar 2014)
  141. Write in brief the immunophenotyping of haematolymphoid neoplasms by flow cytometry. Discuss the utility as compared to conventional immunohistochemistry (JIPMER Mar 2014)
  142. Prognostic factors in acute lymphoblastic leukemia (JIPMER OCT 2015)
  143. Molecular pathogenesis of acute myeloid leukemia (JIPMER Mar 2015)